“Impact of Bulky & Liposomal Secukinumab on Lymphocytes of Psoriatic Patients, to Determine the Improvement in Bioavailability of Secukinumab Nanolipo”. American Journal of Life Science and Innovation 4, no. 1 (June 15, 2025): 27–35. Accessed April 17, 2026. https://e-pallipublishers.com/index.php/ajlsi/article/view/3268.